Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fujioka

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Nihon Geka Gakkai Zasshi|September 1, 1992
[The fate of patients with intermittent claudication-comparison of surgical and non-surgical treatment]K Fujioka, S Toyota, A Furutani, et al.
Neuroscience Letters|July 20, 1992
Protective effect of NGF atelocollagen mini-pellet on the hippocampal delayed neuronal death in gerbilsS Yamamoto, T Yoshimine, T Fujita, et al.
International Journal of Obesity (2005)|June 23, 2016
The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapyK Fujioka, R Plodkowski, P M O'Neil, et al.
Uchu Seibutsu Kagaku|December 1, 1994
Sustained release of hCG minipellet for newt experiment in spaceM Imamizo, M Yoshida, K Fujioka, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1990
Determination of pulmonary microvascular reflection coefficient in sheep by venous occlusionT Isago, L D Traber, D N Herndon, et al.
Diabetes, Obesity & Metabolism|January 12, 2005
Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studiesK Fujioka, R L Brazg, I Raz, et al.
Journal of Human Hypertension|February 13, 2002
Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitorsF G McMahon, S P Weinstein, E Rowe, et al.
Clinical Nuclear Medicine|June 10, 1998
The effects of new platelet inhibitory drug E-5510 on platelet deposition on aortic bifurcation grafts: assessment by indium-111-oxime labeled platelet imagingK Suga, K Nishigauchi, N Kume, et al.
Surgery Today|January 1, 1993
Sequential bypass for multisegmental occlusive diseaseK Fujioka, N Akiyama, K Yoshimura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2001
Development of a new drug delivery system for protein drugs using silicone (II)M Kajihara, T Sugie, T Hojo, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Nihon Geka Gakkai Zasshi|September 1, 1992
[The fate of patients with intermittent claudication-comparison of surgical and non-surgical treatment]K Fujioka, S Toyota, A Furutani, et al.
Neuroscience Letters|July 20, 1992
Protective effect of NGF atelocollagen mini-pellet on the hippocampal delayed neuronal death in gerbilsS Yamamoto, T Yoshimine, T Fujita, et al.
International Journal of Obesity (2005)|June 23, 2016
The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapyK Fujioka, R Plodkowski, P M O'Neil, et al.
Uchu Seibutsu Kagaku|December 1, 1994
Sustained release of hCG minipellet for newt experiment in spaceM Imamizo, M Yoshida, K Fujioka, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1990
Determination of pulmonary microvascular reflection coefficient in sheep by venous occlusionT Isago, L D Traber, D N Herndon, et al.
Diabetes, Obesity & Metabolism|January 12, 2005
Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studiesK Fujioka, R L Brazg, I Raz, et al.
Journal of Human Hypertension|February 13, 2002
Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitorsF G McMahon, S P Weinstein, E Rowe, et al.
Clinical Nuclear Medicine|June 10, 1998
The effects of new platelet inhibitory drug E-5510 on platelet deposition on aortic bifurcation grafts: assessment by indium-111-oxime labeled platelet imagingK Suga, K Nishigauchi, N Kume, et al.
Surgery Today|January 1, 1993
Sequential bypass for multisegmental occlusive diseaseK Fujioka, N Akiyama, K Yoshimura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2001
Development of a new drug delivery system for protein drugs using silicone (II)M Kajihara, T Sugie, T Hojo, et al.
Pageof 12